Back to CRNX
WELLINGTON MANAGEMENT GROUP LLP → CRNX
WELLINGTON MANAGEMENT GROUP LLP CRNX Position History
Crinetics Pharmaceuticals Inc • Healthcare
Quarters held
21
Latest value
$8.4M
Q2 2026
Peak value
$323.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $323.8M |
| Q4 2025 | $5.5M |
| Q4 2025 | $454K |
| Q4 2025 | $3.6M |
| Q4 2025 | $28.7M |
| Q4 2025 | $2.3M |
| Q4 2025 | $9.8M |
| Q1 2026 | $258.2M |
| Q1 2026 | $3.9M |
| Q1 2026 | $484K |
| Q1 2026 | $2.8M |
| Q1 2026 | $21.3M |
| Q1 2026 | $1.7M |
| Q1 2026 | $7.8M |
| Q2 2026 | $237M |
| Q2 2026 | $1.3M |
| Q2 2026 | $115K |
| Q2 2026 | $2.7M |
| Q2 2026 | $17.2M |
| Q2 2026 | $88K |
| Q2 2026 | $8.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $8.4M | 225.1K | — | — |
| Q2 2026 | $88K | 2.4K | — | — |
| Q2 2026 | $17.2M | 459.5K | — | — |
| Q2 2026 | $2.7M | 72.6K | — | — |
| Q2 2026 | $115K | 3.1K | — | — |
| Q2 2026 | $1.3M | 34.8K | — | — |
| Q2 2026 | $237M | 6.33M | — | — |
| Q1 2026 | $7.8M | 215.1K | — | — |
| Q1 2026 | $1.7M | 47.1K | — | — |
| Q1 2026 | $21.3M | 586.7K | — | — |
| Q1 2026 | $2.8M | 77.4K | — | — |
| Q1 2026 | $484K | 13.3K | — | — |
| Q1 2026 | $3.9M | 108.3K | — | — |
| Q1 2026 | $258.2M | 7.11M | — | — |
| Q4 2025 | $9.8M | 211.3K | — | — |
| Q4 2025 | $2.3M | 49.6K | — | — |
| Q4 2025 | $28.7M | 616.7K | — | — |
| Q4 2025 | $3.6M | 78.1K | — | — |
| Q4 2025 | $454K | 9.8K | — | — |
| Q4 2025 | $5.5M | 117.6K | — | — |
| Q4 2025 | $323.8M | 6.95M | — | — |
Other funds holding CRNX
$533.8M
$486.3M
$472.6M
$466.4M
$377M
$363.3M